Nevada Cancer Institute — Las Vegas, Nevada

Nevada Cancer Institute is a clinical research site located in Las Vegas, Nevada, United States 89135.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Nevada Cancer Institute has participated in 68 clinical trials.

Therapeutic areas: Cancer, Diffuse Large-Cell Lymphoma, Peripheral T-cell Lymphoma.

Sponsors: Endocyte, CTI BioPharma, Acrotech Biopharma Inc..

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nevada Cancer Institute?

Nevada Cancer Institute has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nevada Cancer Institute conducted?

Nevada Cancer Institute has 68 clinical trials on record. Their work covers Cancer, Diffuse Large-Cell Lymphoma, Peripheral T-cell Lymphoma.

Is Nevada Cancer Institute accredited by Crixeo Health?

Nevada Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nevada Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.